TRANSSYNOVIAL DISTRIBUTION AND PROTEIN-BINDING OF PIRAZOLAC IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:19
作者
KUROWSKI, M
DUNKY, A
GEDDAWI, M
机构
[1] FREE UNIV BERLIN,INST PHARM,D-1000 BERLIN 33,FED REP GER
[2] KRANKENHAUS STADT VIENNA LAINZ,A-1130 VIENNA,AUSTRIA
[3] SCHERING AG,D-1000 BERLIN 10,FED REP GER
关键词
D O I
10.1007/BF00981129
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:307 / 311
页数:5
相关论文
共 8 条
[1]  
BACHMANN F, 1980, BIOL MED, V2, P153
[2]  
BIERE H, 1982, EUR J MED CHEM, V17, P27
[3]   COMPARISON OF OCCULT BLOOD-LOSS CAUSED BY PIRAZOLAC AND DICLOFENAC SODIUM - A DOUBLE-BLIND CROSSOVER STUDY [J].
BOWN, RL ;
MARTIN, BK ;
GEDDAWI, M .
CURRENT MEDICAL RESEARCH AND OPINION, 1985, 9 (08) :548-551
[4]  
FENNER H, 1982, FORTSCHR MED, V100, P1723
[5]  
SYMONS D, 1985, CURR MED RES OPIN, V9, P542
[6]   PHARMACOKINETICS OF PIRAZOLAC - A NEW ANTI-INFLAMMATORY DRUG IN HUMAN VOLUNTEERS .1. ABSORPTION, DISPOSITION, BIOTRANSFORMATION AND EXCRETION [J].
TAUBER, U ;
WEISS, C ;
KRAUSE, W ;
ACKSTEINER, B ;
MATTHES, H .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1985, 10 (01) :41-53
[7]  
TAUBER U, 1985, PHARMACEUT RES, V4, P188
[8]  
WERNER H, 1985, THESIS FREIE U BERLI